Home » Topics » BioWorld Science

BioWorld Science
RSS

Preliminary evidence suggests a good safety profile of MLN-2704 in prostate cancer patients

June 14, 2004

Draxis Health highlights first quarter progress

June 14, 2004

Penwest highlights first quarter developments

June 14, 2004

InterMune achieves many objectives during Q1 2004

June 14, 2004

Kyorin concludes R&D commission contract with The Scripps Research Institute

June 14, 2004

Encouraging phase I results for aminocandin for systemic fungal infections

June 14, 2004

Aphton begins Swiss regulatory submission for G17DT

June 14, 2004

MediciNova acquires anxiety compound from Mitsubishi

June 14, 2004

Vanda acquires rights to iloperidone from Novartis

June 14, 2004

New phase II program for KRX-0401

June 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...